Stay updated on Moderna Press Releases
Sign up to get notified when there's something new on the Moderna Press Releases page.
Latest updates to the Moderna Press Releases page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe stock price increased from $122.46 to $122.89, and trading volume rose significantly from 92,665 to 267,886, alongside the announcement of David Rubenstein joining Moderna's Board of Directors.SummaryDifference2%
- Check5 days agoNo Change Detected
- Check16 days agoChange DetectedThe stock price has increased to $117.44 with higher trading volume, and there is an announcement for Moderna's second quarter financial results on August 1, 2024.SummaryDifference3%
- Check18 days agoChange DetectedThe website now shows a new joint agreement between Moderna and Mitsubishi Tanabe Pharma Corporation to promote Moderna's mRNA respiratory vaccine portfolio in Japan, including COVID-19 vaccines.SummaryDifference4%
- Check25 days agoChange DetectedThe value on the webpage has changed to July 2, 2024, indicating that Moderna has received a project award through BARDA's Rapid Response Partnership Vehicle Consortium to accelerate the development of an mRNA-based pandemic influenza vaccine.SummaryDifference4%
- Check29 days agoChange DetectedThe EMA Committee For Medicinal Products For Human Use has adopted a positive opinion recommending the marketing authorization of Moderna's RSV vaccine, mRESVIA(R) on June 28, 2024.SummaryDifference4%
- Check31 days agoChange DetectedThe value on the webpage has recently changed to June 25, 2024, which signifies the release of Moderna's Third Annual ESG Report focusing on the impact on human health.SummaryDifference3%
Stay in the know with updates to Moderna Press Releases
Enter your email address, and we'll notify you when there's something new on the Moderna Press Releases page.